US Stock MarketDetailed Quotes

vTv Therapeutics (VTVT)

Watchlist
  • 35.695
  • -2.735-7.12%
Close May 15 16:00 ET
  • 35.695
  • 0.0000.00%
Post 16:10 ET
140.59MMarket Cap-45.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

vTv Therapeutics (VTVT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
36.84M
0
0
0
0
0
1.02M
17K
0
0
Operating revenue
--36.84M
--0
--0
--0
--0
--0
--1.02M
--17K
--0
--0
Cost of revenue
Gross profit
Operating expense
108.77%13.58M
30.21%32.81M
60.62%7.89M
64.45%10.7M
7.91%7.72M
-1.87%6.5M
-1.20%25.2M
4.29%4.91M
21.20%6.51M
-10.56%7.16M
Selling and administrative expenses
25.18%4.6M
9.49%14.95M
48.67%3.98M
12.10%3.68M
-2.64%3.62M
-7.67%3.67M
14.65%13.65M
4.13%2.68M
29.01%3.28M
12.30%3.72M
-General and administrative expense
25.18%4.6M
9.49%14.95M
48.67%3.98M
12.10%3.68M
-2.64%3.62M
-7.67%3.67M
14.65%13.65M
4.13%2.68M
29.01%3.28M
12.30%3.72M
Research and development costs
217.24%8.98M
54.69%17.86M
74.93%3.91M
117.74%7.02M
19.31%4.1M
6.83%2.83M
-15.07%11.55M
4.49%2.23M
14.16%3.22M
-26.69%3.44M
Operating profit
457.73%23.26M
-35.68%-32.81M
-61.18%-7.89M
-64.45%-10.7M
-7.91%-7.72M
-15.57%-6.5M
5.18%-24.18M
-3.93%-4.89M
-21.20%-6.51M
10.56%-7.16M
Net non-operating interest income expense
153.17%838K
19.11%1.86M
101.40%864K
-21.83%394K
-50.27%275K
318.99%331K
240.96%1.57M
429.63%429K
296.85%504K
266.23%553K
Non-operating interest income
153.17%838K
19.49%1.87M
101.63%865K
-20.83%399K
-50.27%275K
318.99%331K
231.57%1.57M
387.50%429K
284.73%504K
261.44%553K
Non-operating interest expense
----
--6K
--1K
--5K
----
----
--0
--0
--0
--0
Other net income (expense)
173.33%33K
-1,460.00%-136K
-550.00%-117K
-124.69%-40K
-65.80%66K
87.87%-45K
101.08%10K
-85.95%26K
104.91%162K
-69.75%193K
Other non- operating income (expenses)
173.33%33K
-1,460.00%-136K
-550.00%-117K
-124.69%-40K
-65.80%66K
87.87%-45K
101.08%10K
-85.95%26K
104.91%162K
-69.75%193K
Income before tax
488.19%24.13M
-37.49%-31.08M
-60.87%-7.14M
-77.14%-10.35M
-15.15%-7.38M
-5.03%-6.22M
12.94%-22.61M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
Income tax
0
0
0
0
0
0
100K
0
0
0
Net income
488.19%24.13M
-36.89%-31.08M
-60.87%-7.14M
-77.14%-10.35M
-15.15%-7.38M
-3.29%-6.22M
12.56%-22.71M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
Net income continuous Operations
488.19%24.13M
-36.89%-31.08M
-60.87%-7.14M
-77.14%-10.35M
-15.15%-7.38M
-3.29%-6.22M
12.56%-22.71M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
Minority interest income
0
3.23%-4.11M
0
-55.82%-1.65M
-8.54%-1.33M
2.51%-1.13M
25.77%-4.24M
16.61%-803K
43.96%-1.06M
22.80%-1.23M
Net income attributable to the parent company
573.96%24.13M
-46.11%-26.97M
-96.42%-7.14M
-81.85%-8.7M
-16.72%-6.05M
-4.67%-5.09M
8.83%-18.46M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
573.96%24.13M
-46.11%-26.97M
-96.42%-7.14M
-81.85%-8.7M
-16.72%-6.05M
-4.67%-5.09M
8.83%-18.46M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
Basic earnings per share
351.95%1.94
0.00%-3.2
-5.45%-0.58
-22.73%-1.08
-13.58%-0.92
34.19%-0.77
67.04%-3.2
67.07%-0.55
72.41%-0.88
69.89%-0.81
Diluted earnings per share
314.29%1.65
0.00%-3.2
-5.45%-0.58
-22.73%-1.08
-13.58%-0.92
34.19%-0.77
67.04%-3.2
67.07%-0.55
72.41%-0.88
69.89%-0.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 36.84M000001.02M17K00
Operating revenue --36.84M--0--0--0--0--0--1.02M--17K--0--0
Cost of revenue
Gross profit
Operating expense 108.77%13.58M30.21%32.81M60.62%7.89M64.45%10.7M7.91%7.72M-1.87%6.5M-1.20%25.2M4.29%4.91M21.20%6.51M-10.56%7.16M
Selling and administrative expenses 25.18%4.6M9.49%14.95M48.67%3.98M12.10%3.68M-2.64%3.62M-7.67%3.67M14.65%13.65M4.13%2.68M29.01%3.28M12.30%3.72M
-General and administrative expense 25.18%4.6M9.49%14.95M48.67%3.98M12.10%3.68M-2.64%3.62M-7.67%3.67M14.65%13.65M4.13%2.68M29.01%3.28M12.30%3.72M
Research and development costs 217.24%8.98M54.69%17.86M74.93%3.91M117.74%7.02M19.31%4.1M6.83%2.83M-15.07%11.55M4.49%2.23M14.16%3.22M-26.69%3.44M
Operating profit 457.73%23.26M-35.68%-32.81M-61.18%-7.89M-64.45%-10.7M-7.91%-7.72M-15.57%-6.5M5.18%-24.18M-3.93%-4.89M-21.20%-6.51M10.56%-7.16M
Net non-operating interest income expense 153.17%838K19.11%1.86M101.40%864K-21.83%394K-50.27%275K318.99%331K240.96%1.57M429.63%429K296.85%504K266.23%553K
Non-operating interest income 153.17%838K19.49%1.87M101.63%865K-20.83%399K-50.27%275K318.99%331K231.57%1.57M387.50%429K284.73%504K261.44%553K
Non-operating interest expense ------6K--1K--5K----------0--0--0--0
Other net income (expense) 173.33%33K-1,460.00%-136K-550.00%-117K-124.69%-40K-65.80%66K87.87%-45K101.08%10K-85.95%26K104.91%162K-69.75%193K
Other non- operating income (expenses) 173.33%33K-1,460.00%-136K-550.00%-117K-124.69%-40K-65.80%66K87.87%-45K101.08%10K-85.95%26K104.91%162K-69.75%193K
Income before tax 488.19%24.13M-37.49%-31.08M-60.87%-7.14M-77.14%-10.35M-15.15%-7.38M-5.03%-6.22M12.94%-22.61M0.09%-4.44M31.62%-5.84M11.12%-6.41M
Income tax 000000100K000
Net income 488.19%24.13M-36.89%-31.08M-60.87%-7.14M-77.14%-10.35M-15.15%-7.38M-3.29%-6.22M12.56%-22.71M0.09%-4.44M31.62%-5.84M11.12%-6.41M
Net income continuous Operations 488.19%24.13M-36.89%-31.08M-60.87%-7.14M-77.14%-10.35M-15.15%-7.38M-3.29%-6.22M12.56%-22.71M0.09%-4.44M31.62%-5.84M11.12%-6.41M
Minority interest income 03.23%-4.11M0-55.82%-1.65M-8.54%-1.33M2.51%-1.13M25.77%-4.24M16.61%-803K43.96%-1.06M22.80%-1.23M
Net income attributable to the parent company 573.96%24.13M-46.11%-26.97M-96.42%-7.14M-81.85%-8.7M-16.72%-6.05M-4.67%-5.09M8.83%-18.46M-4.49%-3.63M28.12%-4.78M7.81%-5.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 573.96%24.13M-46.11%-26.97M-96.42%-7.14M-81.85%-8.7M-16.72%-6.05M-4.67%-5.09M8.83%-18.46M-4.49%-3.63M28.12%-4.78M7.81%-5.18M
Basic earnings per share 351.95%1.940.00%-3.2-5.45%-0.58-22.73%-1.08-13.58%-0.9234.19%-0.7767.04%-3.267.07%-0.5572.41%-0.8869.89%-0.81
Diluted earnings per share 314.29%1.650.00%-3.2-5.45%-0.58-22.73%-1.08-13.58%-0.9234.19%-0.7767.04%-3.267.07%-0.5572.41%-0.8869.89%-0.81
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -